Post Profile






St. Jude Gene Therapy Improves Immunity in Babies with 'Bubble Boy' Disease

Preliminary findings indicate gene therapy pioneered at St. Jude Children's Research Hospital is safe and effective for babies with a devastating inherited disorder that leaves them with little or no immune protection
read more

share

Related Posts


New grant expands reach of St. Jude gene therapy program for 'bubble boy' disease

Health : EurekAlert: Health

(St. Jude Children's Research Hospital) The California Institute for Regenerative Medicine has awarded a five-year, $11.9 million grant to St. Jude Children's Research Hospital and collaborators to deliver gene therapy to patients w...

Gene therapy pioneered at St. Jude shows early success against 'Bubble Boy' disease

Academics / General Science : Science Codex

Adolescents and young adults with a severe inherited immunodeficiency disorder improved following treatment with novel gene therapy developed at St. Jude Children's Research Hospital and at the National Institute of Allergy and Infe...

UCLA Stem Cell Researchers Use Gene Therapy to Restore Immune Systems in "Bubble Babies"

Health : Newswise Medical News

UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two ...

St. Jude gene therapy improves immunity in babies with 'bubble boy' disease

Academics / General Science : Science Codex

Early evidence suggests that gene therapy developed at St. Jude Children's Research Hospital will lead to broad protection for infants with the devastating immune disorder X-linked severe combined immunodeficiency disorder. Prelimin...

Gene Therapy Pioneered at St. Jude Shows Early Success Against "Bubble Boy" Disease

Health : Newswise Medical News

Early results suggest novel gene therapy is safe and effective for treatment of inherited immune disease, according to St. Jude Children's Research Hospital and the National Institute of Allergy and Infectious Diseases.

Comments


Copyright © 2016 Regator, LLC